VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q2 2024

Top Holdings10 positions

Checking export access…
Activity:
AGGAGG
ETF

iShares Core U.S. Aggregate Bond ETF

2.6M$251.7M34.6%$91.47-2.45%
17 qtrssince 2020-Q2
Increased
87
TLTTLT
ETF

iShares 20 Year Treasury Bond ETF

2.5M$227M31.2%$91.28-8.44%
9 qtrssince 2022-Q2
Unchanged
0
IVVIVV
ETF

iShares Core S&P 500 ETF

288,190$157.7M21.7%$392.23+35.61%
17 qtrssince 2020-Q2
Increased
63
VUGVUG
ETF

VANGUARD INDEX FDS

95,790$35.8M4.9%$34.90+76.77%
8 qtrssince 2022-Q3
Unchanged
0
VCSHVCSH
ETF

VANGUARD SHORT-TERM CORP BOND ETF

219,600$17M2.3%$70.390.00%
1 qtr
New
76
IWFIWF
ETF

iShares Russell 1000 Growth ETF

39,315$14.3M2.0%$248.00+46.03%
8 qtrssince 2022-Q3
Unchanged
0
106,600$8.2M1.1%——
1 qtr
New
66
IGSBIGSB
ETF

iShares Short-Term Corporate Bond ETF

136,700$7M1.0%$46.570.00%
1 qtr
New
56
VTVVTV
ETF

Vanguard Value ETF

36,300$5.8M0.8%$119.29+28.22%
9 qtrssince 2022-Q2
Unchanged
0
IWDIWD
ETF

ISHARES RUSSELL 1000 VALUE E

12,300$2.1M0.3%$143.37+18.28%
9 qtrssince 2022-Q2
Unchanged
0
$726.7M
AUM
10
Positions
Q2 2024
Filing
HI score · 1.0/5
Quarterly 13F Value Change
+5%Q1'23$600.2M+10%Q2'23$660.4M-7%Q3'23$613.3M+22%Q4'23$749.8M-19%Q1'24$604.4M+20%Q2'24$726.7M
Activity profile
$ moved · Q2'24
New26%Increased74%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q0%1-4Q0%1-2Y20%2Y+80%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $726.7M across 10 positions as of Q2 2024. Top holdings: AGG (34.6%), TLT (31.2%), IVV (21.7%). Fund DNA: Steady Compounder. HoldingsIntel Score: 1/5.0.

Q2 2024 Summary

Added 3 new positions, increased 2. Top move: AGG (INCREASED, conviction 87). Portfolio: $727M across 10 positions.

Top holdings by portfolio weight

Total AUM$727M
AGG34.64%
TLT31.24%
IVV21.70%
VUG4.93%
VCSH2.33%
IWF1.97%
Vanguard Sho1.13%
IGSB0.96%
VTV0.80%
IWD0.30%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L84
Conviction49
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVanguard Index Funds MORNINGSTAR GROWTH ETF
Q3 2025 → Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAVANTIS EMERGING MARKETS EQUITY ETF
Q4 2025 → Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVanguard International Equity Index Funds FTSE EMR MKT ETF
Q1 2026 → Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used